But simply because numerous youngsters access 88 pounds—regarded as being an adult bodyweight—the FDA has permitted extensions of EUAs for prescription drugs including monoclonal antibodies and remdesivir in youthful age groups, adds Dr. Topal. Having said that, which treatments has to be included and who qualifies for coverage differs from